Articles on Cell Therapy

Cell therapy is reshaping treatment paradigms across multiple disease areas. In this category, biotech professionals can access insights into innovative cell engineering techniques, manufacturing processes, and the clinical applications driving next-generation therapies.

Featured Article

CDH17: A Safe CAR-T Target for Treatment of Solid Tumors

Chimeric antigen receptor T cell (CAR-T) therapy has been successful in the field of hematological malignancies, but it is not effective in solid tumors. However, this situation may be about to change.

Browse articles by topic:

The Rise of Allogeneic Cell Therapies: Strategies, Challenges, and Clinical Advances

April 8, 2025

7 min read

CDH17: A Safe CAR-T Target for Treatment of Solid Tumors

July 19, 2022

5 min read

The New Frontier in SCLC Treatment: 4 Antigens Driving Antibody Innovation

June 25, 2025

9 min read

STEAP1, the next blockbuster target for Prostate Cancer

June 16, 2025

5 min read

AAV Capsid Optimization and Precision Quantification: Customized AAV ELISA Detection Solutions

June 4, 2025

2 min read

Targeted Therapies for Inflammatory Bowel Disease (IBD)

May 28, 2025

6 min read

The Landscape of GPCR-targeting Antibody Drug Development

May 9, 2025

9 min read

For Better Symptom Relief: Targeted Therapy for Asthma

April 15, 2025

11 min read

At the Crossroads of Metabolic and Cancer Therapeutics — GDF15

April 1, 2025

7 min read

NPR1: Major Drug Target for Heart Failure

February 25, 2025

5 min read

Immunotherapy Target: CD19 Antigen

February 4, 2025

7 min read

Case Review: Exploring domain proteins in antibody development

January 22, 2025

8 min read

GDF-8 (Myostatin) antibody Apitegromab achieves success in Phase III clinical trial

June 13, 2024

4 min read

MSLN Targeted Drugs Entering the Fast Lane

February 29, 2024

5 min read

1 2
The Rise of Allogeneic Cell Therapies: Strategies, Challenges, and Clinical Advances

April 8, 2025

7 min read

CDH17: A Safe CAR-T Target for Treatment of Solid Tumors

July 19, 2022

5 min read

MRGPRX2: A Promising Target for Antibody Discovery in Allergy and Pain Disorders

October 28, 2024

6 min read

New Momentum for Integrin Drugs: Integrin αvβ6

June 19, 2024

4 min read

TM4SF1 in Cancer Immunotherapy: Emerging Research and Clinical Potential

September 5, 2022

5 min read

Why Endotoxin Testing Matters: Safeguarding Recombinant Protein Applications in Immunology and Drug Discovery

May 22, 2025

4 min read

MASP2 Antibody Successful in Phase III Clinical Trial

February 10, 2025

5 min read

Emerging New Therapeutic Targets for Obesity

January 14, 2025

7 min read

Targeting Obesity: GLP-1R/GIPR, GDF8 Leading the Way

December 10, 2024

7 min read

Activin Signaling Pathway: Therapeutic Potential Across Disease Frontiers

November 25, 2024

7 min read

Exploring TSLP: A Major Player in Inflammatory Pathways

July 2, 2024

4 min read

Fat Loss and Muscle Gain: Targeting the Activin Signaling Pathway

May 30, 2024

4 min read

Deciphering LY6G6D - An Emerging Target in Colorectal Cancer

February 7, 2024

4 min read

Focusing on the Neuroendocrine Tumor Target SEZ6

January 2, 2024

4 min read

The Role of Delta-like Ligand 3 (DLL3) in Targeted Therapy for Cancer

November 27, 2023

5 min read

Advancing Breast Cancer Research: Uniting for Progress on World Breast Cancer Research Day 2023

August 18, 2023

1 min read

Exploring the Role of MICA in Tumor Immunity and Targeted Therapies

July 6, 2023

4 min read

1 2
Nanodiscs: A Versatile Platform for Membrane Protein Research

April 28, 2025

8 min read

Addressing Challenging Antibody Discovery Targets with Virus-like Particle (VLP) Transmembrane Proteins

October 2, 2024

5 min read

Virus-like Particles: What they are and what they can o in Antibody Discovery

August 28, 2024

6 min read

Ensuring Safe and Effective Gene Therapy with Precise AAV Capsid Quantification

March 25, 2025

6 min read

Breaking News: KACTUS GMP-Grade Cas9 Powers Bioheng’s Breakthrough IND Clearance for Next-Gen UCAR-T Therapy

March 5, 2025

4 min read

Effective Serratia marcescens Nuclease for DNA & RNA Removal: MaxNuclease™

February 21, 2025

3 min read

Panorama of CRISPR Gene Editing Clinical Applications: 2024 Review

January 31, 2025

8 min read

NK Cell Therapy Gets IND FDA Clearance with AccuBase® Base Editor from KACTUS

November 21, 2024

5 min read

2024 Milestones in CRISPR Clinical Pipelines

November 11, 2024

5 min read

Base Editing vs. CRISPR: Navigating Precision Gene Therapy

October 14, 2024

5 min read

AccuBase™ Base Editor Continues to Advance NK Cell Therapies

July 31, 2024

4 min read

IND Approval for Solid Tumor Therapy Using KACTUS Cas9 Enzyme

July 24, 2024

4 min read

Gene Editing Drugs from the EMA Review Perspective

June 25, 2024

5 min read

FDA New Guidelines Pave the Way for Gene Editing Drug Development

April 24, 2024

2 min read

Base Editing Technology Leads a New Chapter in Drug Development

February 14, 2024

5 min read

1 2

Have questions? Get in touch!

support@kactusbio.us